Profiel
Dakshina Reddy worked as an Executive Director of Drug Regulatory Affairs at Galectin Therapeutics, Inc. and as a Director of Global Program Regulatory at Novartis AG.
From 2022 to 2024, Mr. Reddy served as the Vice President of Regulatory Affairs at Altimmune, Inc. Mr. Reddy completed a graduate degree at the University of the Witwatersrand and an undergraduate degree at Rhodes University.
Eerdere bekende functies van Dakshina Reddy
| Bedrijven | Functie | Einde |
|---|---|---|
| ALTIMMUNE, INC. | General Counsel | 01-03-2024 |
| NOVARTIS AG | Corporate Officer/Principal | - |
| GALECTIN THERAPEUTICS INC. | Corporate Officer/Principal | - |
Opleiding van Dakshina Reddy
| University of the Witwatersrand | Graduate Degree |
| Rhodes University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| GALECTIN THERAPEUTICS INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| ALTIMMUNE, INC. | Health Technology |
